Mehta Sanjana, Nain Parminder, Agrawal Bimal K, Singh Rajinder Pal
Maharishi Markandeshwar College of Pharmacy (Deemed to be University), Department of Pharmacy Practice, Haryana, India
Maharishi Markandeshwar Institute of Medical Science and Research (Deemed to be University), Department of Medicine, Haryana, India
Turk J Pharm Sci. 2022 Apr 29;19(2):161-167. doi: 10.4274/tjps.galenos.2021.62357.
: This study evaluates the effect of vitamin D with calcium supplementation on glycemic control and quality of life (QoL) in patients with diabetes.
: A prospective, observational, open-label randomized, controlled study was conducted on 150 type-2 patients with diabetes. A total number of patients were divided into three groups (n= 50 in each group) i.e. group 1 (patient on oral hypoglycemic agents), group 2 (oral hypoglycemic agents with vitamin D 60.000 IU/week), and group 3 (oral hypoglycemic agents, vitamin D 60.000 IU/week along with daily calcium of 1.000 mg/day). Biochemical estimation of fasting/random blood glucose (RBG), hemoglobin A1c (HbA1c), serum insulin and patient’s QoL were analyzed using modified diabetes QoL (MDQoL)-17 questionnaire after 12 weeks of treatment. Data were analyzed using a student -test (paired -test).
: The majority of the patients were male (more than 50%) with an average age of 50 ± 6 years having a diabetic history of more than 10 years and HbA1c level >10% in all three groups. After 12 weeks supplementation, the mean value of vitamin D was 25.73 ± 6.2 ng/mL, 29.98 ± 5.3 ng/mL and 62.71 ± 7.8* ng/mL in groups 1, 2, and 3, respectively (<0.05) compared to baseline. A change in the mean value of HbA1c, in group 2 (14.64 ± 3.48 to 13.99 ± 3.16%) and group 3 (14.05 ± 2.65 to 12.04 ± 2.21%) was also seen at the end of the study. Moreover, patients showed a positive effect of vitamin D with calcium in group 3 with increased MDQoL, 30% of patients were in more than 70 score range.
: The result of the study indicates that vitamin D supplementation with calcium significantly controlled or reduced HbA1c; fasting and RBG levels moreover improve QoL in type-2 patients with diabetes. It suggests that this combination can be considered a therapeutic supplement along with a primarily used anti-diabetic regimen.
本研究评估补充维生素D和钙对糖尿病患者血糖控制及生活质量(QoL)的影响。
对150例2型糖尿病患者进行了一项前瞻性、观察性、开放标签随机对照研究。患者共分为三组(每组n = 50),即第1组(口服降糖药治疗的患者)、第2组(口服降糖药加每周60000 IU维生素D)和第3组(口服降糖药、每周60000 IU维生素D加每日1000 mg钙)。治疗12周后,使用改良糖尿病生活质量(MDQoL)-17问卷分析空腹/随机血糖(RBG)、糖化血红蛋白(HbA1c)、血清胰岛素的生化指标及患者的生活质量。数据采用学生t检验(配对t检验)进行分析。
大多数患者为男性(超过50%),平均年龄50±6岁,糖尿病病史超过10年,三组患者的糖化血红蛋白水平均>10%。补充12周后,第1、2、3组维生素D的平均值分别为25.73±6.2 ng/mL、29.98±5.3 ng/mL和62.71±7.8* ng/mL(与基线相比,P<0.05)。研究结束时,第2组(从14.64±3.48%降至13.99±3.16%)和第3组(从14.05±2.65%降至12.04±2.21%)的糖化血红蛋白平均值也出现了变化。此外,第3组患者显示维生素D加钙有积极作用,MDQoL增加,30%的患者得分超过70分。
研究结果表明,补充维生素D和钙可显著控制或降低糖化血红蛋白;空腹血糖和随机血糖水平,此外还可改善2型糖尿病患者的生活质量。这表明这种联合用药可被视为主要抗糖尿病治疗方案之外的一种治疗补充剂。